NPA chief exec calls CPE a distribution committee, not negotiator
The head of the National Pharmacy Association has publicly questioned the core function of the Committee for Pharmacy Engagement, describing it as a body that distributes funding rather than negotiates for it. The remarks mark a notable moment of candour from one of the sector's leading representative voices.
What happened
The NPA chief executive said that CPE is "not really a negotiating committee", characterising it instead as "a distribution committee". The distinction being drawn is significant. A negotiating body would be expected to go to the table with government and NHS England, argue a position, apply pressure, and secure a better deal. A distribution committee takes what's on offer and works out how to divide it.
The comment didn't come with caveats or walk-backs. It was a direct statement about the structural reality of how CPE operates, at least in the view of the NPA's chief executive.
Why it matters
For anyone working in community pharmacy, this is the kind of internal debate that rarely breaks into public view. Representative bodies tend to project unity when they can. Saying out loud that the body nominally responsible for pharmacy contract negotiations isn't really negotiating is a pointed critique — and one that has been building in the sector for some time.
CPE — the Community Pharmacy England (formerly known as the Pharmaceutical Services Negotiating Committee or PSNC, rebranded in 2023) — is the body that formally negotiates the community pharmacy contractual framework with NHS England and the Department of Health and Social Care. On paper, it represents all NHS community pharmacy contractors in England. In practice, the relationship between CPE and bodies like the NPA has long been one of tension as much as alignment.
The NPA represents independent pharmacy owners specifically. The Company Chemists' Association represents large multiple pharmacy chains. The Independent Pharmacies Association represents a further segment of owner-operators. These three bodies sit alongside CPE but are not the same as it. The question of whether they all pull in the same direction — and whether CPE actually fights for the sector or simply manages whatever settlement government is willing to offer — gets to the heart of why community pharmacy funding has remained under pressure for years.
When the NPA chief executive draws the line between negotiating and distributing, they're making an argument about agency. If CPE is a distribution committee, then the real decisions about how much money flows into community pharmacy are being made elsewhere — in Treasury spending reviews, in NHS England planning rounds, in ministerial offices — and pharmacy's representative structures are largely managing the aftermath rather than shaping the outcome.
That framing has real consequences for how the sector thinks about political strategy. If traditional negotiation through CPE isn't delivering, the question becomes: what will?
GPhC exam relevance
The GPhC Common Registration Assessment doesn't test sector politics directly, but it does test knowledge of pharmacy governance, the contractual framework, and the structures that govern how pharmacies operate within the NHS. Understanding who negotiates the pharmacy contract, what CPE does, and how representative bodies relate to each other is background knowledge that sits underneath several domains in the assessment.
More practically, candidates who understand the funding pressures in community pharmacy will be better placed to answer scenario questions about dispensing services, hub-and-spoke models, clinical services, and the business pressures that drive workforce decisions. A pharmacy that's running on a tight margin because of frozen or cut dispensing fees makes different decisions about staffing, services, and clinical risk than one with adequate funding. That context matters when you're working through a scenario about a dispensary under pressure.
The distinction the NPA chief executive is drawing — between a body that negotiates and one that distributes — also connects to broader questions about professional advocacy and the role pharmacists play in shaping the systems they work within. The GPhC standards expect registrants to act professionally and to contribute to the development of pharmacy practice. That doesn't stop at the dispensary counter.
For the purposes of exam preparation, candidates should be clear on the following:
Community Pharmacy England (CPE) is the body that negotiates the NHS community pharmacy contractual framework in England on behalf of pharmacy contractors. It was previously known as PSNC and rebranded in 2023.
The NPA (National Pharmacy Association) is a trade association and representative body for independent community pharmacy owners. It provides business support, legal advice, and lobbying services to its members.
The pharmacy contractual framework sets out the terms under which NHS pharmacy services are provided, including essential services (dispensing, repeat dispensing, disposal of unwanted medicines, promotion of healthy lifestyles, signposting, and support for self-care), advanced services, and locally commissioned services.
The tension the NPA chief executive is describing — between having a formal negotiating body and actually achieving meaningful funding settlements — reflects a structural problem that has characterised community pharmacy's relationship with NHS commissioners for well over a decade. Real-terms cuts to the global sum, frozen dispensing fees, rising operational costs: these are the conditions that produced the comment.
What's next
The comments from the NPA chief executive raise questions about whether the sector's representative structures will shift. If the view takes hold that CPE functions as a distribution mechanism rather than a genuine negotiating force, there's likely to be renewed pressure on how the sector approaches government relations — more direct lobbying, more public campaigning, more cross-party parliamentary engagement.
Watch for any formal response from CPE to the characterisation. If it pushes back publicly, that signals the body believes it has a stronger mandate than the NPA is acknowledging. If it doesn't respond, that silence will be read as a concession that something needs to change.
For pre-reg candidates, the practical takeaway is to keep an eye on developments in the community pharmacy contract and funding settlement as they approach their assessment. The landscape of services pharmacies can offer, and the pressures they operate under, directly affects the clinical and professional scenarios you'll face on day one of practice.
Source: Chemist+Druggist — https://www.chemistanddruggist.co.uk/news/funding/cpe-not-really-a-negotiating-committee-says-npa-chief-exec-H6Y7KGPVHVBUZDEHWSUDVTDACE/